Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

The integration of PD-1 inhibitors into standard chemotherapy and radiotherapy regimens has revolutionized nasopharyngeal carcinoma treatment, yet only a minority of patients achieve durable responses ...

Clinical trial data demonstrates how Bio-Techne's (TECH) spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomarkers in immunotherapy and targeted ...

Derived from early pandemic waves and needing recalibration for new variants, these renal markers and IL 10 could act as ...

MELBOURNE, Fla., Feb. 18, 2026 /PRNewswire/ -- The Preeclampsia Foundation announced today the launch of a new educational resource to help obstetricians and gynecologists better understand the ...

A large international study reports no overlap between the biological signatures of early depression and psychosis.

—Using multimodal imaging, this 10-year prospective cohort study identified markers that could help stratify patients at high risk of progressing to advanced AMD, which may help inform clinical ...

Immunotherapy, particularly ICIs, shows potential in treating certain STS subtypes, but efficacy varies and requires further investigation. Blood-based biomarkers, including neutrophil-to-lymphocyte ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.